Drug Withdrawals/Restricted Sale
106 - 120 of
152 Results
Sort Results:
Article:
Genentech is pulling Raptiva (efalizumab) from the market due to the risk of an opportunistic brain infection called PML
May 2009
Article:
Metoclopramide will have a new black box warning about the risk for tardive dyskinesia
April 2009
Article:
OTC Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the ma
February 2009